Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 1, 2005, Pages 31-37

  Freeman, K ^a   Oakley, L ^b   Pollak, A ^c   Buffolano, W ^d   Petersen, E ^e   Semprini, A E ^f   Salt, A ^g   Gilbert, R ^g  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CLINICAL TRIAL; CONGENITAL TOXOPLASMOSIS; DELIVERY; DISEASE ASSOCIATION; EUROPE; FEMALE; GESTATIONAL AGE; HUMAN; LABOR INDUCTION; LOW BIRTH WEIGHT; MULTICENTER STUDY; PARITY; PREMATURE LABOR; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROCONVERSION; SMALL FOR DATE INFANT; TOXOPLASMOSIS;

ABORTION, INDUCED; ADULT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MATERNAL AGE; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 11844269275     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00299.x     Document Type: Article

References (22)

1. Dunn D, Wallon M, Peyron F, Petersen E, Peckham CS, Gilbert RE. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353:1829-1833.
2. Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001;30:1309-1330.
3. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicentre study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;180:410-415.
4. Guerina NG, Hsu HW, Meissner HC, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group [see comments]. N Engl J Med 1994;330:1858-1863.
5. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl 1992;84:32-37.
6. Evengard B, Petterson K, Engman M-L, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001;127:121-127.
7. Jenum PA, Stray Pedersen B, Melby KK, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998; 36:2900-2906.
8. Paul M, Petersen E, Pawlowski ZS, Szczapa J. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondü-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J 2000;19:30-36.
9. Neto EC, Anele E, Rubim R, et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 2000;29:941-947.
10. Ancelle T, Goulet V, Tirard-Fleury V, et al. La Toxoplasmose chez la femme enceinte en France en 1995. Resultats d'une enquete nationale perinatale. Bull Epidemiol Hebd 1996;51:227-229.
11. Kliegman RM, Uptpala GD. Intrauterine growth retardation. In: Fanaroff AA, Martin RJ, editors. Neonatal-Perinatal Medicine Diseases of the Fetus and Infant. St. Louis: Mosby, 2002:228-262.
12. Hohlfeld P, Daffos F, Thulliez P, et al. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment [see comments]. J Pediatr 1989;115:765-769.
13. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767-774.
14. EMSCOT. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Br J Obstet Gynaecol 2003;110:112-120.
15. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17-24.
16. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal and fetal loss: population based register linkage study. BMJ 2000;320:1708-1712.
17. Der G, Everitt BS. Multiple regression: determinants of crime rates in the United States. In: Der G, Everitt BS, editors. A Handbook of Statistical Analyses Using SAS. Boca Raton, Florida: Chapman & Hall/CRC, 2001:79-100.
18. Andersen AM, Vastrup P, Wohlfahrt J, Andersen PK, Olsen J, Melbye M. Fever in pregnancy and risk of fetal death: a cohort study. Lancet 2002;360:1552-1556.
19. Gilmore DH, McNay MB. Spontaneous fetal loss rate in early pregnancy. Lancet 1985;1:107.
20. Morris JA, Gardner MJ. Epidemiological studies. In: Altman DG, Machin D, Bryant TN, Gardner MJ, editors. Statistics with Confidence. Bristol: BMJ Books, 2000:57-72.
21. Gilmore DH, McNay MB. Spontaneous fetal loss rate in early pregnancy. Lancet 1985;1:107.
22. Sever JL, Ellenberg JH, Ley AC, et al. Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies. Pediatrics 1988;82: 181-192.